======= SLC2A1 ======= == Gene Information == * **Official Symbol**: SLC2A1 * **Official Name**: solute carrier family 2 member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6513|6513]] * **UniProt**: [[https://www.uniprot.org/uniprot/P11166|P11166]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC2A1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC2A1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/138140|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq, Apr 2013]. * **UniProt Summary**: Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses. {ECO:0000269|PubMed:18245775, ECO:0000269|PubMed:19449892}. |MFS 1| |Sugar tr| |D-glucose transmembrane transporter activity| |lactose biosynthetic process| |lactose metabolic process| |response to Thyroglobulin triiodothyronine| |disaccharide biosynthetic process| |dehydroascorbic acid transport| |dehydroascorbic acid transmembrane transporter activity| |xenobiotic transmembrane transporter activity| |female pronucleus| |L-ascorbic acid metabolic process| |cellular hyperosmotic response| |disaccharide metabolic process| |glucose transmembrane transporter activity| |oligosaccharide biosynthetic process| |xenobiotic transport| |hyperosmotic response| |glucose transmembrane transport| |cellular response to osmotic stress| |hexose transmembrane transport| |monosaccharide transmembrane transport| |carbohydrate transmembrane transport| |vitamin transport| |cellular response to glucose starvation| |intercalated disc| |oligosaccharide metabolic process| |cortical actin cytoskeleton| |protein self-association| |cellular carbohydrate biosynthetic process| |regulation of glucose transmembrane transport| |caveola| |carbohydrate transport| |response to osmotic stress| |cellular response to mechanical stimulus| |water-soluble vitamin metabolic process| |kinase binding| |sarcolemma| |melanosome| |cerebral cortex development| |vitamin metabolic process| |carbohydrate biosynthetic process| |Z disc| |blood microparticle| |cellular response to starvation| |midbody| |cellular carbohydrate metabolic process| |pallium development| |regulation of insulin secretion| |female pregnancy| |response to starvation| |basolateral plasma membrane| |monosaccharide metabolic process| |regulation of peptide hormone secretion| |multi-multicellular organism process| |response to mechanical stimulus| |response to insulin| |cellular response to nutrient levels| |coenzyme metabolic process| |telencephalon development| |cellular response to extracellular stimulus| |regulation of hormone secretion| |cellular response to abiotic stimulus| |cellular response to environmental stimulus| |apical plasma membrane| |cellular response to external stimulus| |response to hypoxia| |response to decreased oxygen levels| |response to oxygen levels| |forebrain development| |response to peptide hormone| |cofactor metabolic process| |organic anion transport| |regulation of protein secretion| |response to peptide| |carbohydrate metabolic process| |regulation of peptide secretion| |response to nutrient levels| |response to extracellular stimulus| |regulation of hormone levels| |regulation of transmembrane transport| |anion transport| |Golgi membrane| |regulation of protein transport| |regulation of peptide transport| |brain development| |regulation of establishment of protein localization| |regulation of secretion by cell| |head development| |regulation of secretion| |response to hormone| |carboxylic acid metabolic process| |central nervous system development| |multi-organism reproductive process| |response to organonitrogen compound| |oxoacid metabolic process| |organic acid metabolic process| |regulation of protein localization| |identical protein binding| |response to nitrogen compound| |response to abiotic stimulus| |transmembrane transport| |ion transport| |integral component of plasma membrane| |reproductive process| |reproduction| |response to endogenous stimulus| |response to oxygen-containing compound| |protein-containing complex assembly| |cellular response to stress| |small molecule metabolic process| |protein-containing complex subunit organization| |regulation of transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-2.4| |[[:results:exp447|Amiloride 100μM R08 exp447]]|-1.74| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|-1.7| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.73| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|1.74| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|1.77| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|1.82| |[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|1.84| |[[:results:exp19|Etoposide 1μM R00 exp19]]|1.85| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|1.86| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|1.86| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|1.88| |[[:results:exp485|GSK626616 14μM R08 exp485]]|1.89| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.94| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|1.96| |[[:results:exp517|Quercetin 20μM R08 exp517]]|2.13| |[[:results:exp79|Q15 2.7μM R02 exp79]]|2.17| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|2.18| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|2.19| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|2.25| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.28| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|2.28| |[[:results:exp182|IU1-47 25μM R04 exp182]]|2.3| |[[:results:exp211|AICAR 240μM R05 exp211]]|2.61| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.63| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|2.65| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|3.79| ^Gene^Correlation^ |[[:human genes:p:pfkp|PFKP]]|0.599| |[[:human genes:h:hk2|HK2]]|0.564| |[[:human genes:g:gpi|GPI]]|0.538| |[[:human genes:p:pgp|PGP]]|0.491| |[[:human genes:h:hk1|HK1]]|0.479| Global Fraction of Cell Lines Where Essential: 86/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|5/28| |blood|1/28| |bone|4/26| |breast|3/33| |central nervous system|3/56| |cervix|0/4| |colorectal|2/17| |esophagus|6/13| |fibroblast|0/1| |gastric|0/16| |kidney|3/21| |liver|2/20| |lung|18/75| |lymphocyte|2/16| |ovary|2/26| |pancreas|3/24| |peripheral nervous system|2/16| |plasma cell|7/15| |prostate|0/1| |skin|0/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|4/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13 * **Expression level (log2 read counts)**: 6.67 {{:chemogenomics:nalm6 dist.png?nolink |}}